NTcell group would need to show clear markers of improvement, as if both groups faired poorly it wouldnt matter if the implant was merely less worse than the placebo
the placebo group does not have to fair well, it merely should not show same improved markers to the extent the NTcell group shows
- Forums
- ASX - By Stock
- 1AI
- Passing Through the 20's
Passing Through the 20's, page-114
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 1AI (ASX) to my watchlist
|
|||||
Last
0.8¢ |
Change
0.001(6.67%) |
Mkt cap ! $13.49M |
Open | High | Low | Value | Volume |
0.7¢ | 0.8¢ | 0.7¢ | $2.215K | 279.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 5292072 | 0.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.8¢ | 42589 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 5292072 | 0.007 |
15 | 9360084 | 0.006 |
6 | 2510009 | 0.005 |
4 | 4065000 | 0.004 |
2 | 4590000 | 0.003 |
Price($) | Vol. | No. |
---|---|---|
0.008 | 42589 | 1 |
0.009 | 1430539 | 9 |
0.010 | 3949573 | 9 |
0.011 | 1490400 | 3 |
0.012 | 816363 | 4 |
Last trade - 13.23pm 21/08/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |